Toll-like receptor 9 expression is associated with breast cancer sensitivity to the growth inhibitory effects of bisphosphonates in vitro and in vivo

Jouko Sandholm, Jaakko Lehtimäki, Tamiko Ishizu, Sadanandan E. Velu, Jeremy Clark, Pirkko Härkönen, Arja Jukkola-Vuorinen, Aleksi Schrey, Kevin W. Harris, Johanna M. Tuomela, Katri S. Selander

Research output: Contribution to journalArticleScientificpeer-review

8 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)87373–87389
Number of pages17
JournalOncotarget
Volume7
Issue number52
DOIs
Publication statusPublished - 2016
MoE publication typeA1 Journal article-refereed

Keywords

  • ApppI
  • biomarker
  • bisphosphonate
  • breast cancer
  • TLR9

Cite this